Crossmark

Neoadjuvant Pembrolizumab Enables Successful Downstaging and Resection of Borderline Resectable MSI-H/dMMR Pancreatic Ductal Adenocarcinoma: A Case Report and Literature Review

Crossref DOI link: https://doi.org/10.1007/s12029-025-01237-5

Published Online: 2025-05-08

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Kevin

Muralidharan, Vijayaragavan https://orcid.org/0000-0001-8247-8937
Brown, Shaun

Upton, Anthony

Alshimirti, Moammar

Cooray, Prasad D. https://orcid.org/0009-0003-7230-2374
Funding

Funding for this research was provided by:

University of Melbourne
License Information

Text and Data Mining valid from 2025-05-08

Version of Record valid from 2025-05-08
More Information

Article History

Accepted: 29 April 2025

First Online: 8 May 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below